• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP

CYNATA THERAPEUTICS LIMITED - Discussion

5.56% ! 17.0¢
Market Cap $38.41M  !
Healthcare Biotechnology
Add to My Watchlist

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Cynata Therapeutics Limited

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Rossi70 32 8.1K 3 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 22 4.8K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread Rossi70 22 4.8K 2 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 22 4.8K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread Rossi70 22 4.8K 5 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Artephius 32 8.1K 4 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread gavint66 32 8.1K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 22 4.8K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 22 4.8K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread bedger 22 4.8K 3 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread truss20 32 8.1K 8 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread truss20 22 4.8K 6 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread gavint66 32 8.1K 1 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 22 4.8K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread atomikrej 32 8.1K 4 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread bedger 22 4.8K 8 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread truss20 22 4.8K 4 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread Artephius 22 4.8K 4 19/05/25
19/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 22 4.8K 1 19/05/25
19/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 1
ASX - By Stock CYP Paving the way for next-gen treatments Thread Artephius 22 4.8K 8 19/05/25
19/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 4.8K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Ann: Promising Preclinical Heart Disease Data Thread gavint66 10 4.1K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 10 Views Created with Sketch. 4.1K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Promising Preclinical Heart Disease Data Thread Rossi70 10 4.1K 3 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 10 Views Created with Sketch. 4.1K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: Investor Webinar Thread Pronewbie 22 7.3K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 7.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Cynata Participating in Euroz Hartleys Investor Conference Thread Pronewbie 9 2.8K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 2.8K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Cynata Participating in Euroz Hartleys Investor Conference Thread Pronewbie 9 2.8K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 2.8K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Investor Webinar Thread Pronewbie 11 2.8K 2 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 2.8K Likes Created with Sketch. 2
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Pronewbie 354 98K 3 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: Promising Preclinical Heart Disease Data Thread Pronewbie 10 4.1K 2 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 10 Views Created with Sketch. 4.1K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 5.3K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 5.3K 2 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 5.3K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 5.3K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 5.3K 2 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 5.3K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 5.3K 2 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 5.3K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 5.3K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 5.3K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 5.3K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 354 98K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 6
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 5.3K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread reginaldp 354 98K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 354 98K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 5.3K 3 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread reginaldp 354 98K 9 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 9
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread bedger 32 8.1K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Bazsa 26 5.3K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 5.3K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 5.3K 3 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Aremac 26 5.3K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 5.3K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 5.3K 3 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 5.3K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 5.3K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Pronewbie 32 8.1K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Doug Diamond 32 8.1K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread truss20 32 8.1K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 5
ASX - By Stock CYP Ann: CYP-001s FDA Approval Pathway Not Impeded Thread ASX News 32 8.1K 17 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 32 Views Created with Sketch. 8.1K Likes Created with Sketch. 17
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread bedger 354 98K 8 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 8
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread bedger 354 98K 7 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 7
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 5.3K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Bazsa 26 5.3K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Doug Diamond 354 98K 8 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Ann: Investor Webinar Thread tuts 11 2.8K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 2.8K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Valueformoney 26 5.3K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread coolkiat 354 98K 4 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 5.3K 4 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Rossi70 354 98K 7 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 7
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread coolkiat 354 98K 6 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 5.3K 1 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 5.3K 8 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 5.3K Likes Created with Sketch. 8
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Aremac 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread coolkiat 354 98K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Aremac 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 354 98K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 1 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 354 98K 2 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 2
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 354 98K 6 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 6
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 354 98K 4 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Stockcount 354 98K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Stockcount 354 98K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 354 98K 6 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 6
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 1 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 354 98K 5 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 5
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 354 98K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 354 Views Created with Sketch. 98K Likes Created with Sketch. 0
refresh Created with Sketch. REFRESH

Featured News

NEWS Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)
right-arrow Created with Sketch.
NEWS Bonanza Dittmer Drilling Hits 221g/t Gold in Stage 5 Intersection
right-arrow Created with Sketch.
NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
NEWS New Positive Interim Data in Phase 2 Study of SNT-5505 in Myelofibrosis
right-arrow Created with Sketch.
NEWS Building Permits Received for Phase One Renewable Power Plant
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
17.0¢ 		Change
-0.010(5.56%) 		Mkt cap ! $38.41M
Open High Low Value Volume
17.0¢ 17.0¢ 16.5¢ $21.40K 127.0K

Buyers (Bids)

No. Vol. Price($)
9 425750 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 90178 3
View Market Depth
Last trade - 14.06pm 13/06/2025 (20 minute delay) ?
CYP (ASX) Chart

Top Stories

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Welcome to this week’s HotCopperWire, our market watch podcast!Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through all the week’s biggest news headlines @ and what they mean for Aussie investors.In this Week ...
Resolution's dual-listing to 'expedite growth' – and sets stage for NASDAQ foray Resolution Minerals (ASX:RML) is on the verge of listing on the OTCQB @ oft called the @Venture Market” over in the States @ as it looks to @expedite growth” and @unlock value” through the bold U.S. index expansion.Listen to the Ho...
Zip's stunning comeback: Is this the start of a $14 revival? Just when the market had written it off… Zip Co (ASX: ZIP) has come roaring back to life. The Buy Now, Pay Later company stunned investors last Wednesday with a 15% surge in its share price soon after upgrading its full-year earnings forecast to at least $160 million @ up from $153 million...
Clinuvel shares dip, even as CEO comes back from temp leave After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...
'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits Advance Metals (ASX:AVM) has started its maiden drilling at the Yoquivo Silver-Gold Project in Mexico with a bang...

Featured News

NEWS Bonanza Dittmer Drilling Hits 221g/t Gold in Stage 5 Intersection
right-arrow Created with Sketch.
VMM Viridis Selected for BNDES and FINEP Strategic Mineral Funding to Advance Colossus Project
right-arrow Created with Sketch.
NEWS Building Permits Received for Phase One Renewable Power Plant
right-arrow Created with Sketch.
NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
NEWS New Positive Interim Data in Phase 2 Study of SNT-5505 in Myelofibrosis
right-arrow Created with Sketch.
NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.